I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cui, Xiaoteng
159
results:
Search for persons
X
Format
Online (159)
Mediatypes
Articles (Online) (83)
OpenAccess-fulltext (76)
Sorted by: Relevance
Sorted by: Year
?
1
CRISPR-Cas9 library screening combined with an exosome-targ..:
Zhao, Jixing
;
Cui, Xiaoteng
;
Zhan, Qi
...
Theranostics. 14 (2024) 7 - p. 2835-2855 , 2024
Link:
https://doi.org/10.7150/..
?
2
Retraction Notice to: Precise editing of FGFR3-TACC3 fusion..:
Wu, Ye
;
Jin, Weili
;
Wang, Qixue
...
Molecular Therapy. 32 (2024) 6 - p. 2036 , 2024
Link:
https://doi.org/10.1016/..
?
3
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances th..:
Yang, Eryan
;
Hong, Biao
;
Wang, Yunfei
...
Cancer Letters. 588 (2024) - p. 216812 , 2024
Link:
https://doi.org/10.1016/..
?
4
RUNX1/NPM1/H3K4me3 complex contributes to extracellular mat..:
Cui, Xiaoteng
;
Huo, Dawei
;
Wang, Qixue
...
Cell Death & Disease. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
5
HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modul..:
Yang, Shixue
;
Zhan, Qi
;
Su, Dongyuan
...
Neuro-Oncology. 26 (2024) 8 - p. 1405-1420 , 2024
Link:
https://doi.org/10.1093/..
?
6
EGC enhances tumor antigen presentation and CD8+ T cell-med..:
Zhang, Xinxin
;
Cui, Xiaoteng
;
Li, Peiying
...
Cancer Letters. 592 (2024) - p. 216934 , 2024
Link:
https://doi.org/10.1016/..
?
7
Deep‐targeted gene sequencing reveals ARID1A mutation as an..:
Xiao, Menglin
;
Cui, Xiaoteng
;
Xu, Can
...
CNS Neuroscience & Therapeutics. 30 (2024) 4 - p. , 2024
Link:
https://doi.org/10.1111/..
?
8
MUC1 promotes glioblastoma progression and TMZ resistance b..:
Tong, Fei
;
Zhao, Ji-xing
;
Fang, Zi-yuan
...
Pharmacological Research. 187 (2023) - p. 106606 , 2023
Link:
https://doi.org/10.1016/..
?
9
EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction in..:
Hong, Biao
;
Yang, Eryan
;
Su, Dongyuan
...
Neuro-Oncology. 26 (2023) 1 - p. 100-114 , 2023
Link:
https://doi.org/10.1093/..
?
10
Blockage of EGFR/AKT and mevalonate pathways synergize the ..:
Cui, Xiaoteng
;
Zhao, Jixing
;
Li, Guanzhang
...
Cancer Communications. 43 (2023) 12 - p. 1326-1353 , 2023
Link:
https://doi.org/10.1002/..
?
11
EPIC-0307-mediated selective disruption of PRADX–EZH2 inter..:
Xin, Lei
;
Tan, Yanli
;
Zhu, Yuanxue
...
Neuro-Oncology. , 2023
Link:
https://doi.org/10.1093/..
?
12
Editorial: Innovative theranostic approaches towards neuro-..:
Cui, Xiaoteng
;
Zhai, Lijie
;
Kang, Chunsheng
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
13
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the N..:
Yi, Kaikai
;
Cui, Xiaoteng
;
Liu, Xing
...
Frontiers in Immunology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
14
A novel compound EPIC-0412 reverses temozolomide resistance..:
Zhao, Jixing
;
Yang, Shixue
;
Cui, Xiaoteng
...
Neuro-Oncology. 25 (2022) 5 - p. 857-870 , 2022
Link:
https://doi.org/10.1093/..
?
15
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Ce..:
Xu, Can
;
Zhao, Jixing
;
Song, Jia
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
1-15